Scientists are now investigating whether GLP-1 drugs could help treat substance use disorders, which also involve dopamine-driven reward pathways
Gorgojo-Martinez JJ, Mezquita-Raya P, Carretero-Gomez J, Castro A, Cebrian-Cuenca A, de Torres-Sanchez A, et al
The success of weight loss medication relies on a medical provider who understands your health condition and goals and creates a treatment plan that does not compromise your safety or results
As an example of a combined GLP-1 + FIM intervention, eligible patients could receive both GLP-1 therapy and a FIM intervention emphasizing foods to support weight maintenance, reduce side effects, minimize loss of muscle and bone mass, and promote nutrient adequacy
Similar content being viewed by others Background Glucagon-like peptide-1 (GLP-1) is a peptide hormone known for its role in regulating glucose homeostasis and satiety
Is GLP-1 the Same as Ozempic